Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Page revision updated from v3.4.2 to v3.4.3. No substantive changes to study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-12T02:23:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page and removed the older government funding status notices (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T14:17:00.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a finalized Lancet publication citation for NIVOPOST-OP results and a government funding/status notice; the earlier ahead-of-print citation was replaced.
    Difference
    0.5%
    Check dated 2026-02-04T10:28:49.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and labeling updates: the glossary toggle is now shown, and small wording/casing changes were made to headers and revision information (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0).
    Difference
    0.2%
    Check dated 2026-01-28T06:22:56.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The revision label was updated from v3.3.3 to v3.3.4. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:20:20.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added Publications: Lancet 2025 article on Nivolumab added to cisplatin and radiotherapy for high-risk head and neck cancer, and a From PubMed note indicating automatic citation.
    Difference
    0.3%
    Check dated 2025-12-30T21:09:29.000Z thumbnail image

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.